Exxel Pharma Participates in the Virtual Investor "Top 5 for '25" On-Demand Conference
AURORA, CO / ACCESS Newswire / February 19, 2025 / Exxel Pharma ("Exxel" or the "Company"), a pharmaceutical company dedicated to developing novel therapeutics for the treatment of neuronal hypersensitivity disorders,
Block, Inc. (NYSE: XYZ) has posted its results for the fourth quarter of 2024 on the Financials section of its Investor Relations website at investors.block.xyz.
Swiss Resource Capital AG is pleased to welcome Goldshore Resources Inc. (TSXV:GSHR)(TSXV:SXGC)(ISIN: CA38150N1078) as a new client.
Montevideo, Feb. 20, 2025 (GLOBE NEWSWIRE) -- MercadoLibre, Inc. (Nasdaq: MELI) ( http://www.mercadolibre.com) today reported ...
Enhanced Online Platform Provides Greater Access to TAG's Solar Solutions and Investment DataScottsdale, Arizona--(Newsfile Corp. - February 19, ...
This is an in-person event; no webcast will be available. On March 5 at 1:50 p.m. PST, John Pitzer, corporate vice president, ...
Recent controversies at major companies have highlighted serious flaws in corporate governance, sparking tensions between ...
Ignitis grupe Ignitis Group, a renewables-focused integrated utility, has been recognised for the second consecutive time as one of the top investor relations companies in the Baltics. At the ...
Q4 2024 Earnings Conference Call February 20, 2025 5:00 AM ETCompany ParticipantsJeffrey Wang - Investor Relations DirectorFeng ...
Those who wish to listen to the conference call webcast should visit the Investor Relations section of the Company’s website at The live call also can be accessed using the below dial-in details.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback